- Home
- PBYI vs CIA Comparison
PBYI vs CIA Comparison
Compare PBYI & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- CIA
- Stock Information
- Founded
- PBYI 2010
- CIA 1969
- Country
- PBYI United States
- CIA United States
- Employees
- PBYI N/A
- CIA N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- CIA Life Insurance
- Sector
- PBYI Health Care
- CIA Finance
- Exchange
- PBYI Nasdaq
- CIA Nasdaq
- Market Cap
- PBYI 237.2M
- CIA 261.8M
- IPO Year
- PBYI N/A
- CIA N/A
- Fundamental
- Price
- PBYI $5.41
- CIA $5.80
- Analyst Decision
- PBYI Strong Buy
- CIA
- Analyst Count
- PBYI 1
- CIA 0
- Target Price
- PBYI $7.00
- CIA N/A
- AVG Volume (30 Days)
- PBYI 511.9K
- CIA 147.4K
- Earning Date
- PBYI 11-06-2025
- CIA 11-06-2025
- Dividend Yield
- PBYI N/A
- CIA N/A
- EPS Growth
- PBYI 434.29
- CIA N/A
- EPS
- PBYI 0.97
- CIA 0.22
- Revenue
- PBYI $238,062,000.00
- CIA $245,943,000.00
- Revenue This Year
- PBYI N/A
- CIA $4.22
- Revenue Next Year
- PBYI N/A
- CIA $4.46
- P/E Ratio
- PBYI $5.56
- CIA $26.51
- Revenue Growth
- PBYI 8.63
- CIA N/A
- 52 Week Low
- PBYI $2.32
- CIA $2.90
- 52 Week High
- PBYI $6.07
- CIA $5.99
- Technical
- Relative Strength Index (RSI)
- PBYI 65.34
- CIA 60.03
- Support Level
- PBYI $5.11
- CIA $5.33
- Resistance Level
- PBYI $5.42
- CIA $5.93
- Average True Range (ATR)
- PBYI 0.25
- CIA 0.23
- MACD
- PBYI 0.06
- CIA 0.03
- Stochastic Oscillator
- PBYI 75.36
- CIA 85.21
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.